Investors Research Corp’s Mesoblast MESO Stock Holding History

Investors Research Corp’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1	Closed	–	–	1125
2022 Q1	$0	Buy	+1	New	+$9	﹤0.01%	1069

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return

TFA

Tobias Financial Advisors Plantation, Florida $718M AUM 15.66% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

Investors Research Corp's MESO Position: Q2 2022 in Review

Investors Research Corp sold out of Mesoblast (MESO) in Q2 2022, closing a stake of 1 share.

Investors Research Corp first reported a position in MESO in Q1 2022 and held it in 1 quarter. The position peaked at $0 in Q1 2022. 33 funds tracked by Wall St. Rank hold MESO as of Q2 2022.

Investors Research Corp reported no remaining Mesoblast position as of Q2 2022 after selling out during the quarter.
Investors Research Corp sold 1 Mesoblast share in Q2 2022.
Investors Research Corp first reported a position in Mesoblast in Q1 2022 and held it in 1 quarter.
Investors Research Corp's Mesoblast position peaked at $0 in Q1 2022.
33 funds tracked by Wall St. Rank held Mesoblast as of Q2 2022.

Based on Investors Research Corp's 13F filing for Q2 2022, filed 21 Jul 2022.